Subcutaneous Drug Delivery Equipment Market Key Players Overview and Competitive Breakdown, 2013 – 2028

Global Subcutaneous Drug Delivery Equipment Market is expected to witness a massive growth with a staggering CAGR in the forecast period. A subcutaneous injection is controlled as a bolus into the subcutis, which is clearly the layer of skin straight underneath the epidermis and dermis. They are communally referred to as the cutis and these subcutaneous injections are extremely operational in overseeing vaccines and medications such as goserelininsulin, diacetylmorphine and morphine. Subcutaneous injection, which is opposed to intravenous of recreational drugs can be referred to skin popping. This subcutaneous administration can also be abbreviated as SC, SQ, sub-cu, sub-Q, SubQ, or subcut.

Subcutaneous drug delivery equipment market is driven by rise in incidences of chronic diseases in geriatric population and massive developments in medical devices such as needle and prefilled syringes. Wider availability of patient pool undergoing diabetes treatment is more likely to trigger the demand for subcutaneous drug delivery devices. In addition, manufacturer emphasis on modernized packaging features that enable ease-of-use adds to the demand scenario.

On the other hand, constant R&D for reusable injection devices to enable drug cartridges and prefilled syringes for drug administration is gaining a wide traction.

Get Free Sample Copy of This Report @

The subcutaneous drug delivery equipment market is segmented on the basis of product (auto injectors, subcutaneous implants, syringe based subcutaneous drug delivery, pen systems for subcutaneous delivery, pump based drug delivery systems); by end user (clinic, in-patient, out-patient, others) and by region (North America, Southeast Asia, India, Europe, China, Japan).

Geographically, China and India are expected to occupy the largest market share in the near future. Along with these two regions, Southeast Asia is also likely to witness tremendous progress in the upcoming years. But, North America, which has been a leader in the subcutaneous drug delivery equipment industry will eventually continue to play an important role during the forecast period. In the near future, subcutaneous drug delivery equipment market will continue to come up with new product innovations to attract new consumers and investors, for them to continue the domination.

Some of the prominent key players of the subcutaneous drug delivery equipment industry are Merck, Novartis, Pfizer, Teva Pharmaceutical, Zogenix, Novo Nordisk, Galaxo, HMD pharmaceuticals, Sanofi, Boehringer Ingelheim and Eli Lily. All the leading companies are including mergers and acquisitions, partnerships and joint ventures to enhance the growth of the market.

Browse Related Category Reports @

Matched content

Editor’s pick

Express Press Release Distribution